Literature DB >> 22210916

Clonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation.

Loury Janbazian1, David A Price, Glenda Canderan, Abdelali Filali-Mouhim, Tedi E Asher, David R Ambrozak, Phillip Scheinberg, Mohamad Rachid Boulassel, Jean-Pierre Routy, Richard A Koup, Daniel C Douek, Rafick-Pierre Sekaly, Lydie Trautmann.   

Abstract

Persistent exposure to cognate Ag leads to the functional impairment and exhaustion of HIV-specific CD8 T cells. Ag withdrawal, attributable either to antiretroviral treatment or the emergence of epitope escape mutations, causes HIV-specific CD8 T cell responses to wane over time. However, this process does not continue to extinction, and residual CD8 T cells likely play an important role in the control of HIV replication. In this study, we conducted a longitudinal analysis of clonality, phenotype, and function to define the characteristics of HIV-specific CD8 T cell populations that persist under conditions of limited antigenic stimulation. Ag decay was associated with dynamic changes in the TCR repertoire, increased expression of CD45RA and CD127, decreased expression of programmed death-1, and the emergence of polyfunctional HIV-specific CD8 T cells. High-definition analysis of individual clonotypes revealed that the Ag loss-induced gain of function within HIV-specific CD8 T cell populations could be attributed to two nonexclusive mechanisms: 1) functional improvement of persisting clonotypes; and 2) recruitment of particular clonotypes endowed with superior functional capabilities.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210916      PMCID: PMC3262882          DOI: 10.4049/jimmunol.1102610

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.

Authors:  Stephen A Migueles; Alisha C Laborico; W Lesley Shupert; M Shirin Sabbaghian; Ronald Rabin; Claire W Hallahan; Debbie Van Baarle; Stefan Kostense; Frank Miedema; Mary McLaughlin; Linda Ehler; Julia Metcalf; Shuying Liu; Mark Connors
Journal:  Nat Immunol       Date:  2002-10-07       Impact factor: 25.606

2.  Reversion of CTL escape-variant immunodeficiency viruses in vivo.

Authors:  Thomas C Friedrich; Elizabeth J Dodds; Levi J Yant; Lara Vojnov; Richard Rudersdorf; Candice Cullen; David T Evans; Ronald C Desrosiers; Bianca R Mothé; John Sidney; Alessandro Sette; Kevin Kunstman; Steven Wolinsky; Michael Piatak; Jeffrey Lifson; Austin L Hughes; Nancy Wilson; David H O'Connor; David I Watkins
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

3.  Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.

Authors:  Dan H Barouch; Jennifer Powers; Diana M Truitt; Michael G Kishko; Janelle C Arthur; Fred W Peyerl; Marcelo J Kuroda; Darci A Gorgone; Michelle A Lifton; Carol I Lord; Vanessa M Hirsch; David C Montefiori; Angela Carville; Keith G Mansfield; Kevin J Kunstman; Steven M Wolinsky; Norman L Letvin
Journal:  Nat Immunol       Date:  2005-01-30       Impact factor: 25.606

Review 4.  Structural determinants of T-cell receptor bias in immunity.

Authors:  Stephen J Turner; Peter C Doherty; James McCluskey; Jamie Rossjohn
Journal:  Nat Rev Immunol       Date:  2006-11-17       Impact factor: 53.106

Review 5.  New approaches to design HIV-1 T-cell vaccines.

Authors:  Hélène Perrin; Glenda Canderan; Rafick-Pierre Sékaly; Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

6.  Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response.

Authors:  David J van Bockel; David A Price; Mee Ling Munier; Vanessa Venturi; Tedi E Asher; Kristin Ladell; Hui Yee Greenaway; John Zaunders; Daniel C Douek; David A Cooper; Miles P Davenport; Anthony D Kelleher
Journal:  J Immunol       Date:  2010-12-06       Impact factor: 5.422

7.  Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL.

Authors:  Misty R Jenkins; Katherine Kedzierska; Peter C Doherty; Stephen J Turner
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

8.  Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection.

Authors:  Thomas Vollbrecht; Heike Brackmann; Nadja Henrich; Joerg Roeling; Ulrich Seybold; Johannes R Bogner; Frank D Goebel; Rika Draenert
Journal:  J Med Virol       Date:  2010-03       Impact factor: 2.327

9.  Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy.

Authors:  Sarah Palmer; Frank Maldarelli; Ann Wiegand; Barry Bernstein; George J Hanna; Scott C Brun; Dale J Kempf; John W Mellors; John M Coffin; Martin S King
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

10.  A human memory T cell subset with stem cell-like properties.

Authors:  Luca Gattinoni; Enrico Lugli; Yun Ji; Zoltan Pos; Chrystal M Paulos; Máire F Quigley; Jorge R Almeida; Emma Gostick; Zhiya Yu; Carmine Carpenito; Ena Wang; Daniel C Douek; David A Price; Carl H June; Francesco M Marincola; Mario Roederer; Nicholas P Restifo
Journal:  Nat Med       Date:  2011-09-18       Impact factor: 53.440

View more
  28 in total

Review 1.  Unravelling the mechanisms of durable control of HIV-1.

Authors:  Bruce D Walker; Xu G Yu
Journal:  Nat Rev Immunol       Date:  2013-07       Impact factor: 53.106

Review 2.  Kill: boosting HIV-specific immune responses.

Authors:  Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

3.  Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire.

Authors:  Ryan O Emerson; William S DeWitt; Marissa Vignali; Jenna Gravley; Joyce K Hu; Edward J Osborne; Cindy Desmarais; Mark Klinger; Christopher S Carlson; John A Hansen; Mark Rieder; Harlan S Robins
Journal:  Nat Genet       Date:  2017-04-03       Impact factor: 38.330

4.  Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection.

Authors:  Lydie Trautmann; Florentin-Martial Mbitikon-Kobo; Jean-Philippe Goulet; Yoav Peretz; Yu Shi; Julien Van Grevenynghe; Francesco Andrea Procopio; Mohamad Rachid Boulassel; Jean-Pierre Routy; Nicolas Chomont; Elias K Haddad; Rafick-Pierre Sekaly
Journal:  Blood       Date:  2012-09-06       Impact factor: 22.113

5.  Wake me up before you go: a strategy to reduce the latent HIV reservoir.

Authors:  Nicolas Chomont; Afam A Okoye; David Favre; Lydie Trautmann
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

6.  T-Cell Receptor (TCR) Clonotype-Specific Differences in Inhibitory Activity of HIV-1 Cytotoxic T-Cell Clones Is Not Mediated by TCR Alone.

Authors:  Nina C Flerin; Huabiao Chen; Tynisha D Glover; Pedro A Lamothe; Jian Hua Zheng; Justin W Fang; Zaza M Ndhlovu; Evan W Newell; Mark M Davis; Bruce D Walker; Harris Goldstein
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

7.  The impact of viral evolution and frequency of variant epitopes on primary and memory human immunodeficiency virus type 1-specific CD8⁺ T cell responses.

Authors:  Nada M Melhem; Kellie N Smith; Xiao-Li Huang; Bonnie A Colleton; Weimin Jiang; Robbie B Mailliard; James I Mullins; Charles R Rinaldo
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

Review 8.  PD-1 coinhibitory signals: the link between pathogenesis and protection.

Authors:  Deanna A Kulpa; Mariam Lawani; Anthony Cooper; Yoav Peretz; Jeff Ahlers; Rafick-Pierre Sékaly
Journal:  Semin Immunol       Date:  2013-03-31       Impact factor: 11.130

Review 9.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Cutting edge: Prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells.

Authors:  Ben Youngblood; Alessandra Noto; Filippos Porichis; Rama S Akondy; Zaza M Ndhlovu; James W Austin; Rebeka Bordi; Francesco A Procopio; Toshiyuki Miura; Todd M Allen; John Sidney; Alessandro Sette; Bruce D Walker; Rafi Ahmed; Jeremy M Boss; Rafick-Pierre Sékaly; Daniel E Kaufmann
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.